Assessment of Emergency Spacers Versus Traditional Spacers for Delivery of Aerosolized Drugs
Recruiting
Phase 4
Interventional Study
Asthmatic Patients
MDI
Aerosol Generating Procedure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 6 – 80
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 120 (estimated)
- Sponsor
- Beni-Suef University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
* The goal of this clinical trial is to evaluate the performance, feasibility, and safety of emergency spacers compared to traditional spacers for the delivery of aerosolized drugs using pMDI. in young children and adult asthmatic patients The main questions it aims to answer are:
1. Measuring total emitted dose emitted from pMDI alone and attached to spacers.
2. Determining the pharmacokinet…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
• Mild and moderate asthmatic patients aged from 6 - 80 year old.
Exclusion Criteria:
* Severe asthmatics or patients admitted to an intensive care unit
* ischemic heart disease
* recent abdominal surgery
* inability to perform properly the pulmonary function tests
* hepatic o…
Contacts